← Back to all trials
Completed
NCT05455931
Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)
Conditions: Mycosis Fungoides and Sézary Syndrome
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 73
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd
Location: The Johns Hopkins University School of Medicine Baltimore Maryland
Summary
This is a prospective, observational, non-interventional, international, multi-center, mixed methods study that will involve the integration of quantitative and qualitative data in patients with MF/SS treated with Poteligeo.
Eligibility Criteria
Inclusion Criteria:
1. Patient aged ≥18 years
2. Confirmed diagnosis of MF/SS
3. Disease staging at enrollment has been completed
4. About to commence primary treatment with Poteligeo® as per reimbursed indication
5. Patient is willing and able to complete the symptom diary and PROs.
6. Patient is willing and able to provide written informed consent to participate in the study in a manner approved by Institutional Review Board(IRB)/ Independent Ethics Committee (IEC) and local regulations
Exclusion Criteria:
1. Patient unable to participate in all aspects of the study and/or does not agree to the collection of data from medical records
2. Patient currently participating in an interventional clinical trial
Source: ClinicalTrials.gov (NCT05455931). StuddyBuddy aggregates publicly available trial information.
